Company Filing History:
Years Active: 1996-2009
Title: The Innovative Mind of W Davis Parker
Introduction
W Davis Parker, based in Charlottesville, VA, is a notable inventor with a keen focus on genetic research and its implications for neurodegenerative diseases. With a total of three patents to his name, Parker has made significant contributions to the diagnosis and treatment of conditions such as Parkinson's disease and Alzheimer's disease.
Latest Patents
His latest patents showcase groundbreaking advancements in genetic testing and treatment methodologies. One of his notable inventions addresses mitochondrial ND5 gene mutations in Parkinson's disease. This invention provides methods for diagnosing and treating Parkinson's based on these mitochondrial mutations. Additionally, it offers avenues for diagnosing and treating other diseases linked to similar mitochondrial alterations.
Another significant patent pertains to genetic mutations in mitochondrial cytochrome oxidase genes, which are known to correlate with Alzheimer's disease. This invention not only aids in the detection of such mutations as a diagnostic tool for Alzheimer's but also proposes treatments for dysfunctions associated with cytochrome oxidase.
Career Highlights
Throughout his career, W Davis Parker has been associated with innovative firms like Mitokor, Inc. and Gene Solutions, LLC. These companies have provided a platform for him to advance his research and contribute to the evolving field of genetic science.
Collaborations
Collaboration has also played a vital role in Parker’s work. He has partnered with Corinna Herrnstadt, leveraging their combined expertise to drive forward significant advancements in their projects.
Conclusion
W Davis Parker’s dedication to innovation in the realm of genetics has yielded impactful inventions that aim to enhance our understanding and treatment of debilitating diseases. His contributions underscore the vital intersection of science and technology in improving patient outcomes, particularly for conditions that currently lack effective therapeutic options.